{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T22:56:17Z","timestamp":1771023377291,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1987,1,1]],"date-time":"1987-01-01T00:00:00Z","timestamp":536457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1987,1]]},"DOI":"10.1007\/bf01646125","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T16:46:45Z","timestamp":1115484405000},"page":"60-68","source":"Crossref","is-referenced-by-count":16,"title":["Prophylaxe gramnegativer und grampositiver Infektionen mit drei intraven\u00f6sen Immunglobulin-Pr\u00e4paraten und Therapie der experimentellen polymikrobiellen Verbrennungssepsis mit intraven\u00f6sem Pseudomonas-Immunglobulin G und Ciprofloxacin im Tiermodell","Prophylaxis of Gram-negative and Gram-positive infections in rodents with three intravenous immunoglobulins and therapy of experimental polymicrobial burn wound sepsis with pseudomonas immunoglobulin and ciprofloxacin"],"prefix":"10.1007","volume":"15","author":[{"given":"M. S.","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. F.","family":"Hector","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. E.","family":"Roby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena A.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra K.","family":"Ladehoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H.","family":"Dorsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1987,1,1]]},"reference":[{"issue":"Suppl.","key":"BF01646125_CR1","first-page":"S879","volume":"19","author":"W. W. Monafo","year":"1979","unstructured":"Monafo, W. W. An overview of infection control. J. Trauma 19 (Suppl.) (1979) S879-S880.","journal-title":"J. Trauma"},{"key":"BF01646125_CR2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/00005373-198109000-00001","volume":"21","author":"W. F. McManus","year":"1981","unstructured":"McManus, W. F., Goodwin, C. W., Mason, A. D. jr., Pruitt, B. A. Burn wound infection. J. Trauma 21 (1981) 753\u2013756.","journal-title":"J. Trauma"},{"key":"BF01646125_CR3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1128\/IAI.15.3.776-780.1977","volume":"15","author":"M. Pollack","year":"1977","unstructured":"Pollack, M., Tylor, N. S., Callahan, L. T. Exotoxin production by clinical isolates ofPseudomonas aeruginosa. Infect. Immun. 15 (1977) 776\u2013780.","journal-title":"Infect. Immun."},{"key":"BF01646125_CR4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1128\/IAI.24.1.181-187.1979","volume":"18","author":"O. R. Pavlouskis","year":"1979","unstructured":"Pavlouskis, O. R., Wretlind, B. Assessment of protease (elastase) as aPseudomonas aeruginosa virulence factor in experimental mouse burn infections. Infect. Immun. 18 (1979) 181\u2013187.","journal-title":"Infect. Immun."},{"key":"BF01646125_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/00005373-198306000-00015","volume":"23","author":"M. S. Collins","year":"1983","unstructured":"Collins, M. S., Roby, R. E. Anti-Pseudomonas aeruginosa activity of an intravenous human IgG preparation in burned mice. J. Trauma 23 (1983) 530\u2013534.","journal-title":"J. Trauma"},{"issue":"3A","key":"BF01646125_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/0002-9343(84)90337-1","volume":"76","author":"M. S. Collins","year":"1984","unstructured":"Collins, M. S., Roby, R. E. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens ofPseudomonas aeruginosa. Am. J. Med. 76 (3A) (1984) 168\u2013174.","journal-title":"Am. J. Med."},{"key":"BF01646125_CR7","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1093\/infdis\/147.6.1090","volume":"147","author":"M. Pollack","year":"1983","unstructured":"Pollack, M. Antibody activity againstPseudomonas aeruginosa in immune globulins prepared for intravenous use in humans. J. Infect. Dis. 147 (1983) 1090\u20131098.","journal-title":"J. Infect. Dis."},{"key":"BF01646125_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3181\/00379727-94-22904","volume":"94","author":"S. M. Rosenthal","year":"1957","unstructured":"Rosenthal, S. M., Millican, R. C., Rust, J. A factor in human gammaglobulin preparations active againstPseudomonas aeruginosa infections. Proc. Soc. Exp. Biol. Med. 94 (1957) 214\u2013217.","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BF01646125_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.81.1.29","volume":"81","author":"M. W. Fisher","year":"1958","unstructured":"Fisher, M. W., Manning, M. C. Studies on the immunotherapy of bacterial infections. I. The comparative effectiveness of human gammaglobulin against various bacterial species in mice. J. Immunol. 81 (1958) 29\u201331.","journal-title":"J. Immunol."},{"issue":"Suppl.","key":"BF01646125_CR10","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.1093\/infdis\/136.Supplement.S181","volume":"136","author":"M. W. Fisher","year":"1977","unstructured":"Fisher, M. W. A polyvalent human \u03b3-globulin toPseudomonas aeruginosa: passive protection of mice against lethal infection. J. Infect. Dis. 136 (Suppl.) (1977) S181-S185.","journal-title":"J. Infect. Dis."},{"key":"BF01646125_CR11","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1128\/IAI.39.3.1072-1079.1983","volume":"39","author":"S. J. Cryz","year":"1983","unstructured":"Cryz, S. J., Furer, E., Germanier, R. Protection againstPseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase and antilipopolysaccharide. Infect. Immun. 39 (1983) 1072\u20131079.","journal-title":"Infect. Immun."},{"key":"BF01646125_CR12","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/JB.98.2.835-836.1969","volume":"98","author":"M. W. Fisher","year":"1969","unstructured":"Fisher, M. W., Devlin, H. B., Gnabasik, F. J. New immunotype scheme forPseudomonas aeruginosa based on protective antigens. J. Bacteriol. 98 (1969) 835\u2013836.","journal-title":"J. Bacteriol."},{"issue":"Suppl.","key":"BF01646125_CR13","doi-asserted-by":"publisher","first-page":"S426","DOI":"10.1093\/clinids\/8.Supplement_4.S426","volume":"8","author":"J. E. Pennington","year":"1986","unstructured":"Pennington, J. E., Pier, G. B., Sadoff, J. C., Small, G. J. Active and passive immunization strategies forPseudomonas aeruginosa pneumonia. Rev. Infect. Dis. 8 (Suppl.) (1986) S426-S433.","journal-title":"Rev. Infect. Dis."},{"key":"BF01646125_CR14","first-page":"933","volume":"35","author":"W. Stephan","year":"1985","unstructured":"Stephan, W., Dichtelm\u00fcller, H., Schedel, I. Eigenschaften und Wirksamkeit eines humanen Immunglobulin M-Pr\u00e4parates f\u00fcr die intraven\u00f6se Anwendung. Arzneim. Forsch. 35 (1985) 933\u2013936.","journal-title":"Arzneim. Forsch."},{"key":"BF01646125_CR15","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1073\/pnas.82.6.1790","volume":"82","author":"N. H. Teng","year":"1985","unstructured":"Teng, N. H., Kaplan, H. S., Hebert, J. M., Moore, C., Douglas, H., Wunderlich, A., Braude, A. I. Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proc. Natl. Acad. Sci. USA. 82 (1985) 1790\u20131794.","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BF01646125_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1423-0410.1975.tb02791.x","volume":"28","author":"W. L. Stephen","year":"1975","unstructured":"Stephen, W. L. Undegraded human immunoglobulin for intravenous use. Vox Sang. 28 (1975) 422\u2013437.","journal-title":"Vox Sang."},{"key":"BF01646125_CR17","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/infdis\/151.6.1171","volume":"151","author":"M. S. Collins","year":"1985","unstructured":"Collins, M. S., Dorsey, J. H. Comparativein vivo activity between intravenous immune globulin prepared by reduction and alkylation or by low pH. J. Infect. Dis. 151 (1985) 1171\u20131173.","journal-title":"J. Infect. Dis."},{"key":"BF01646125_CR18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/IAI.8.2.278-290.1973","volume":"8","author":"A. L. Smith","year":"1973","unstructured":"Smith, A. L., Smith, D. H., Averill, D. R. jr., Marino, J., Moxon, E. R. Production ofHaemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect. Immun. 8 (1973) 278\u2013290.","journal-title":"Infect. Immun."},{"key":"BF01646125_CR19","first-page":"19","volume-title":"Probit analysis","author":"D. J. Finney","year":"1971","unstructured":"Finney, D. J. Probit analysis. 3rd ed. London: Cambridge University Press 1971, pp. 19\u201338.","edition":"3rd ed."},{"key":"BF01646125_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJM196208162670701","volume":"267","author":"N. A. Kefalides","year":"1962","unstructured":"Kefalides, N. A., Arana, J. A., Bazan, A., Bocanegra, M., Stastny, P., Velarde, N., Rosenthal, S. M. Role of infection in mortality from severe burns: evaluation of plasma, gamma globulin, albumin and saline solution therapy in a group of Peruvian Children. N. Engl. J. Med. 267 (1962) 317\u2013323.","journal-title":"N. Engl. J. Med."},{"key":"BF01646125_CR21","unstructured":"Stone, H. H., Graber, C. D., Martin, J. D., Kolb, L.: Evaluation of gamma globulin for prophylaxis against burn sepsis. Surgery (1965) 810\u2013814."},{"issue":"3A","key":"BF01646125_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0002-9343(84)90338-3","volume":"76","author":"K. Z. Shirani","year":"1984","unstructured":"Shirani, K. Z., Vaughan, G. M., McManus, A. T., Amy, B. W., McManus, W. F., Pruitt, B. A., Mason, A. D. Replacement therapy with modified immunoglobulin G in burn patients: preliminary kinetic studies. Am. J. Med. 76 (3A) (1984) 175\u2013180.","journal-title":"Am. J. Med."},{"key":"BF01646125_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM196609292751307","volume":"275","author":"F. S. Rosen","year":"1966","unstructured":"Rosen, F. S., Janeway, C. A. The gamma globulins. III. The antibody deficiency syndromes. N. Engl. J. Med. 275 (1966) 709\u2013715.","journal-title":"N. Engl. J. Med."},{"key":"BF01646125_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1423-0410.1981.tb00727.x","volume":"40","author":"M. Ceska","year":"1981","unstructured":"Ceska, M. Binding of protein A to some human gamma globulins used intravenously. Vox Sang. 40 (1981) 395\u2013402.","journal-title":"Vox Sang."},{"key":"BF01646125_CR25","first-page":"1179","volume":"114","author":"J. M. Griffiss","year":"1975","unstructured":"Griffiss, J. M. Bactericidial activity of meningococcal antisera: blocking by IgA of lytic antibody in human convalescent sera. J. Immunol. 114 (1975) 1179\u20131784.","journal-title":"J. Immunol."},{"key":"BF01646125_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1128\/AAC.25.3.319","volume":"25","author":"N. Chin","year":"1984","unstructured":"Chin, N., Neu, H. C. Ciprofloxacin, a quinoline carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob. Agents Chemother. 25 (1984) 319\u2013326.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01646125_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1128\/AAC.25.3.331","volume":"25","author":"G. M. Eliopoulos","year":"1984","unstructured":"Eliopoulos, G. M., Gardella, A., Moellering, R. C. In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent. Antimicrob. Agents Chemother. 25 (1984) 331\u2013335.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01646125_CR28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1128\/AAC.26.5.757","volume":"26","author":"W. Brumfitt","year":"1984","unstructured":"Brumfitt, W., Franklin, I., Grady, O., Hamilton-Miller, J. M. T., Iliffee, A. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob. Agents Chemother. 26 (1984) 757\u2013761.","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Infection"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01646125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01646125\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01646125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T05:19:47Z","timestamp":1683091187000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01646125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1987,1]]}},"alternative-id":["BF01646125"],"URL":"https:\/\/doi.org\/10.1007\/bf01646125","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,1]]}}}